A single dose of HIV DNA vaccine induces long lasting potent HIV-specific T cell responses in Rhesus macaques by Arrode-Brusés, Géraldine et al.
BioMed  Central
Page 1 of 2
(page number not for citation purposes)
Retrovirology
Open Access Poster presentation
A single dose of HIV DNA vaccine induces long lasting potent 
HIV-specific T cell responses in Rhesus macaques
Géraldine Arrode-Brusés1, Darlene Sheffer1, Ramakrishna Hegde1, 
Zhengian Liu1, Francois Villenger2, Opendra Narayan1 and 
Yahia Chebloune*1,3
Address: 1University of Kansas Medical Center, Department of Microbiology, Molecular genetics and Immunology, USA, 2Emory University, 
Atlanta, Georgia, Department of Pathology and Laboratory Medicine, USA and 3INRA, Department of Animal health, France
* Corresponding author    
Background
Use of HIV DNA vaccines in rodents revealed enthusiastic
strong and long lasting immune responses (IR) specific to
all expressed HIV antigens. However, ''le désarroi'' began
when these constructs were used in human and non-
human primates and their immunogenicity was found to
be very weak. To face this désarroi, HIV DNA immuniza-
tions were rapidly associated with heterologous boosts
with recombinant viruses and purified proteins. However,
efforts in many labs were pursued to develop strategies
that increase the immunogenicity of these vaccines.
Among these strategies we have chosen to transpose as
close as possible in Rhesus Macaques, the conditions of
immunization we used in mice [1,2].
Materials and methods
We used a single high dose of our Δ4SHIVKU2 DNA vaccine
to immunize 5 Rhesus monkeys and performed a longitu-
dinal analysis of induced IR using multi-parametric flow
cytometry based assays.
Results
Interestingly, our data showed that all 5 macaques devel-
oped long-lasting, potent T cell immune responses in
their peripheral blood cells (PBMC). A peak of primary
responses was observed during the 4 weeks post-immuni-
zation, and then the response underwent a contraction
phase and later reemerged in absence of any boost. The
great majority of vaccine-specific CD4+and CD8+T cells
did not produce IFN-γ but showed high Ag-specific prolif-
eration capacities. In addition, proliferative CD8+T cells
expressed the lytic Granzyme B. In contrast however, no
antibody response specific to any HIV antigen was
detected. By examining the safety issues we found that this
vaccination strategy was not associated with detectable
proviral integration in the PBMC of immunized animals
and no autoantibody to DNA was detected in sera of these
animals.
Conclusion
Altogether, this first comprehensive analysis with an HIV
DNA vaccine alone given in a single shot demonstrated
for the first time the capacity of this strategy to induce
potent, long-lasting and polyfunctional T cell responses
specific to HIV antigens in NHP.
Acknowledgements
We thank the NIH AIDS Research and Reference Reagents for providing 
HIV reagents. This work was supported by NIH R-01 and Cobre grants and 
INRA Animal Health.
References
1. Arrode G, Hegde R, Mani A, Jin Y, Chebloune Y, Narayan O: Pheno-
typic and functional analysis of immune CD8+ T cell
responses induced by a single injection of a HIV DNA vaccine
in mice.  J Immunol 2007, 178:2318-2327.
from Frontiers of Retrovirology: Complex retroviruses, retroelements and their hosts
Montpellier, France. 21-23 September 2009
Published: 24 September 2009
Retrovirology 2009, 6(Suppl 2):P21 doi:10.1186/1742-4690-6-S2-P21
<supplement> <title> <p>Frontiers of Retrovirology: Complex retroviruses, retroelements and their hosts</p> </title> <note>Meeting abstracts - A single PDF containing all abstracts in this Supplement is available <a href="http://www.biomedcentral.com/content/files/pdf/1742-4690-6-S2-full.pdf">here</a>.</note> <url>http://www.biomedcentral.com/content/pdf/1742-4690-6-S2-info.pdf</url> </supplement>
This abstract is available from: http://www.retrovirology.com/content/6/S2/P21
© 2009 Arrode-Brusés et al; licensee BioMed Central Ltd. Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Retrovirology 2009, 6(Suppl 2):P21 http://www.retrovirology.com/content/6/S2/P21
Page 2 of 2
(page number not for citation purposes)
2. Arrode G, Hegde R, Jin Y, Singh DK, Narayan O, Chebloune Y: Nef
modulates the immunogenicity of Gag encoded in a non-
infectious HIV DNA vaccine.  Vaccine 2008, 26:3795-3804.